Patient Square Capital »

Aeglea Biotherapeutics shares owned by Patient Square Capital

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Patient Square Capital from 13F filings

Historical chart of Patient Square Capital investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Patient Square Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 150k 32.76

More positions owned by Patient Square Capital

Roivant Sciences SHS (ROIV)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Argenx Se Sponsored Adr (ARGX)
Beone Medicines Sponsored Ads (ONC)
Abivax Sa Sponsored Ads (ABVX)
Pharvaris N V (PHVS)
Eyepoint Com New (EYPT)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Cogent Biosciences (COGT)
Kymera Therapeutics (KYMR)
Liquidia Corporation Com New (LQDA)
Dbv Technologies S A Sponsored Ads (DBVT)
Allogene Therapeutics (ALLO)

View all positions for Patient Square Capital

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
VR Adviser
Capital Research and Management Company - Division 3
Perceptive Advisors
Driehaus Capital Management
Commodore Capital
State Street Corporation
TCG Crossover Management
Tang Capital Management
Geode Capital Management
Braidwell

View all funds holding Aeglea Biotherapeutics